Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RAC1 |
| Upstream (Parents) |
|---|
| (<<) BZW2 → RAC1 |
| (<<) HGS → RAC1 |
| (<<) HYAL1 → RAC1 |
| (<<) PNPLA3 → RAC1 |
| (<<) PRSS3 → RAC1 |
| (<<) RNASE4 → RAC1 |
| (<<) SET → RAC1 |
| Downstream (Children) |
|---|
| RAC1 → ACTN4 (>>) |
| RAC1 → ANKRD27 (>>) |
| RAC1 → ASNS (>>) |
| RAC1 → ATP10B (>>) |
| RAC1 → CCNL1 (>>) |
| RAC1 → CFL1 (>>) |
| RAC1 → DUSP10 (>>) |
| RAC1 → DYNLL1 (>>) |
| RAC1 → ELF4 (>>) |
| RAC1 → ENC1 (>>) |
| RAC1 → EPHB2 (>>) |
| RAC1 → ETS2 (>>) |
| RAC1 → FZD4 (>>) |
| RAC1 → GPR153 (>>) |
| RAC1 → IGFBP2 (>>) |
| RAC1 → ITGA2 (>>) |
| RAC1 → ITGB4 (>>) |
| RAC1 → ITPR2 (>>) |
| RAC1 → ITPR3 (>>) |
| RAC1 → KRAS (>>) |
| RAC1 → LGALS3 (>>) |
| RAC1 → MAPK13 (>>) |
| RAC1 → NDST1 (>>) |
| RAC1 → NET1 (>>) |
| RAC1 → NFAT5 (>>) |
| RAC1 → PDE2A (>>) |
| RAC1 → PDIA4 (>>) |
| RAC1 → PLCB4 (>>) |
| RAC1 → PRDX6 (>>) |
| RAC1 → PRKCD (>>) |
| RAC1 → PTK2 (>>) |
| RAC1 → PYGL (>>) |
| RAC1 → RAF1 (>>) |
| RAC1 → RASA1 (>>) |
| RAC1 → RRAS (>>) |
| RAC1 → SLC26A1 (>>) |
| RAC1 → TFPI2 (>>) |
| RAC1 → TSC22D1 (>>) |
| RAC1 → UBE2D1 (>>) |
| RAC1 → UGDH (>>) |
| RAC1 → YWHAB (>>) |
